Jefferies Reports Lower Than Expected First-Quarter Profit

Jefferies Financial Group announced on Wednesday that its first-quarter profit fell short of Wall Street expectations. The investment bank reported weaker performance in bond trading and a slowdown in stock market dealmaking, which the company attributed to uncertainty stemming from evolving U.S. trade policy and ongoing geopolitical tensions.

The results provide an early indication of potential trends in investment banking for the beginning of 2025, particularly in equity underwriting, which has been affected by market volatility and fluctuating demand for initial public offerings (IPOs) and other equity-related transactions.

While some deals have progressed, Jefferies President Brian Friedman noted in an interview that last year's "momentum has been slowed by the uncertainty that has arisen as a result of the policy statements and actions of the government and geopolitical events." This prolonged a three-year period of slower dealmaking activity.

Specifically, Jefferies' revenue from equity underwriting saw a significant decline of 39% in the reported quarter. The capital markets business, encompassing trading desks, reported revenues of $698 million, a decrease of nearly 4% compared to the previous year. Fixed-income net revenues also fell by 18% to $289 million, which the company explained was partly due to a strong prior-year quarter and reduced market volatility leading to lower overall trading volumes.

However, there were positive aspects in the report. Jefferies experienced a 17% increase in advisory revenue due to market share gains and a substantial 54% surge in debt underwriting revenue. These gains contributed to an overall 7% rise in investment banking performance.

Friedman commented on the current environment, stating, "Periods of change and uncertainty generally reduce confidence and visibility until we are able to absorb what is happening and form a perspective." He added that while business executives are taking a cautious approach, they generally view the Trump administration as pro-business and anticipate potential deregulation.

Notable deals Jefferies was involved in during the quarter include acting as a bookrunner for cybersecurity firm SailPoint's $1.4 billion U.S. IPO and serving as a financial advisor to Intra-Cellular Therapies in its $14.6 billion acquisition by Johnson & Johnson.

Following the earnings release, Jefferies' shares experienced a 4% drop in extended trading. Investors will be looking to the upcoming earnings reports from larger competitors such as Morgan Stanley, Goldman Sachs, and JPMorgan Chase next month for a broader understanding of the recovery in Wall Street dealmaking. Unlike some other firms, Jefferies is expected to maintain its current staffing levels after recent hiring initiatives. For the three months ending February 28, Jefferies reported a profit of 57 cents per share, which was below the average analyst estimate of 94 cents per share.